Medicare’s Future

How Could the Price of Remdesivir Impact Medicare Spending for COVID-19 Patients?

  • by

This brief discusses how drugs provided in inpatient hospital settings are covered and reimbursed for beneficiaries in traditional Medicare under current law. This is relevant for Medicare spending on COVID-19 patients who receive Gilead’s new antiviral drug remdesivir. We discuss the implications for hospitals and… Read More »How Could the Price of Remdesivir Impact Medicare Spending for COVID-19 Patients?